Latest filing published 02 Apr 2026 for Vivos Therapeutics, Inc., €1.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -89.8%Entry US$1.31 · Close 22 Oct 2026 US$0.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael C. Skaff: trading record in brief
All filings by Michael C. Skaff on record concern Vivos Therapeutics, Inc. Activity is concentrated on a single trading day, 31 March 2026, with 2 filings.
The open-market record is one-sided, with 2 purchases worth €1.6M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 2 April 2026 with an open-market purchase (€1.2M) in Vivos Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael C. Skaff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,044,777 shares@ US$1.3477.2% of flowCommon StockSEC:0002074003-26-000008:0Canonical exit: 29 Jun 2026 (T+90)
- 308,848 shares@ US$1.3422.8% of flowCommon StockSEC:0002074003-26-000008:1Canonical exit: 29 Jun 2026 (T+90)
2 of 2 declarations